US Broker Ratings

The Cigna Group (CI) Stock Analysis: Unveiling a 23.03% Upside Potential

For investors keen on the healthcare sector, The Cigna Group (NYSE: CI) presents an intriguing opportunity with a potential upside of 23.03% based on the average..

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with a 4.39% Upside Potential

AbbVie Inc. (ABBV), a powerhouse in the healthcare sector, continues to capture investor attention with its robust market presence and promising future prospects. With a market..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 28.93% Upside Potential

AstraZeneca PLC (AZN), a leader in the healthcare sector, stands out in the general drug manufacturing industry with its impressive $257.42 billion market cap. As investors..

PPHE Hotel Group completes $33.5m sale of Manhattan development site

PPHE Hotel Group has completed the sale of its Manhattan development site for $33.5m, with proceeds to be allocated under its capital strategy...

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 79% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, specifically within the biotechnology industry, is making noticeable strides with its innovative suite of..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with a Market Cap of $4.26 Billion

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, operates within the specialized niche of medical devices. With a robust market capitalization of..

iRhythm Holdings (IRTC) Stock Analysis: A 39.87% Upside Opportunity in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, thanks to its innovative approach to cardiac monitoring technology. With a market capitalization of..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: 94.70% Potential Upside Catches Investor Attention

Atrium Therapeutics, Inc. (NASDAQ: RNA) is generating buzz in the biotechnology sector, not only for its innovative approach to RNA-based therapies but also for its significant..

Oscar Health, Inc. (OSCR) Investor Outlook: Evaluating Strong Revenue Growth Amid High RSI Levels

As Oscar Health, Inc. (OSCR) navigates the competitive landscape of the healthcare plans industry, investors are taking note of its impressive market cap of $10.11 billion..

BrightSpring Health Services (BTSG) Investor Outlook: Strong Buy Ratings Highlight a Potential 27.92% Upside

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has emerged as a compelling proposition for investors, particularly within the healthcare sector’s innovative health information services industry. With a..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: 22% Potential Upside Amidst Innovative Gene Therapy Developments

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, stands out with its innovative approach to rare disease treatment. Focused on RNA-targeted therapeutics..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 22.56% Potential Upside on Robust Analyst Confidence

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a Boston-based biotechnology firm, is making waves in the healthcare sector with a promising pipeline targeting rare neuroendocrine diseases. With a..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Potential 48% Upside Sparks Investor Interest

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is stirring significant interest among investors with its promising pipeline of muscle activators and inhibitors..

AptarGroup, Inc. (ATR) Investor Outlook: Potential 28.8% Upside Sparks Interest

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a compelling..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring the 15.87% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $9.83 billion, this..

Guardant Health, Inc. (GH) Stock Analysis: A 23.59% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology sector, a field that is gaining significant traction as technological advancements continue to..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Sleep Apnea Market with a 5.78% Upside Potential

Inspire Medical Systems, Inc. (INSP) is a key player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, the company..

The Ensign Group, Inc. (ENSG) Investor Outlook: Analyzing 21.11% Potential Upside Amid Healthcare Expansion

The Ensign Group, Inc. (NASDAQ: ENSG), a leader in the healthcare sector, primarily operating within the medical care facilities industry, presents a compelling opportunity for investors..

United Therapeutics Corporation (UTHR) Stock Analysis: Potential 30% Upside Captivates Investors

United Therapeutics Corporation (NASDAQ: UTHR) is currently capturing the attention of individual investors with a promising potential upside of 30.72%. Operating in the healthcare sector, United..

Bruker Corporation (BRKR) Stock Analysis: A Close Look at Its 1.82% Potential Upside Amidst Healthcare Sector Dynamics

As the healthcare sector continues to evolve with groundbreaking innovations, Bruker Corporation (NASDAQ: BRKR) stands out as a pivotal player within the medical devices industry. With..

Search

Funds

US Broker Ratings

PPHE Hotel Group completes $33.5m sale of Manhattan development site

PPHE Hotel Group has completed the sale of its Manhattan development site for $33.5m, with proceeds to be allocated under its capital strategy...
Search

Funds

US Broker Ratings

FTSE 100

Funds